GLOW Oncology sets Sept. 17 launch event ahead of GI/GU symposium

GLOW Oncology will hold its official launch event Sept. 17 in Coral Gables, Florida, to support a November patient education symposium focused on gastrointestinal and genitourinary cancers. The nonprofit is highlighting new programming, national recognition and expanded partnerships as it builds a broader platform for patients and caregivers.

Why it matters: - GLOW Oncology is tying its launch to direct patient support, with event proceeds funding education and advocacy for people affected by gastrointestinal and genitourinary cancers. - The nonprofit is pushing into cancer education, clinical trial awareness and health equity at a time when many patients still face barriers to care. - The launch also signals broader momentum for GLOW's partnerships with major cancer centers, advocacy groups and industry sponsors.

What happened: - GLOW Oncology will hold its official launch event on Sept. 17, 2026, in Coral Gables, Florida. - David Yurman is sponsoring the event. - The launch will support GLOW's upcoming Gastrointestinal and Genitourinary Patient Journey Symposium. - The event will bring together leaders from oncology, healthcare, nonprofit, business and philanthropic communities. - The launch will include food, drinks, entertainment and an introduction to GLOW's mission and programs.

The details: - Proceeds from the launch event will support the GI/GU Patient Journey Symposium on Nov. 6, 2026, at Mount Sinai Medical Center in Miami Beach, Florida. - The symposium is designed for patients, caregivers, clinicians, researchers and advocates. - Planned topics include clinical trial access, survivorship, emerging technologies, artificial intelligence, nutrition, patient education and support from diagnosis through treatment and beyond. - Sponsorship and partnership opportunities remain open for organizations that want to support patient education, health equity, clinical trial awareness, survivorship and cancer care innovation. - GLOW Oncology says interested organizations may contact the nonprofit for more information. - Since launching in late 2025, GLOW has expanded its national and international reach through work with healthcare institutions, advocacy organizations, industry partners, clinicians, researchers, patients and caregivers. - GLOW Oncology was selected for two Conquer Cancer scholarships to attend the Annual Meeting of the American Society of Clinical Oncology. - Andrea P. Eidelman received the Power2Voice Award. - The City of Doral issued a proclamation signed by the mayor recognizing Eidelman for health equity, patient advocacy and community engagement. - GLOW Oncology recently launched a Virtual Patient Education and Clinical Trials Education Series on TikTok with Salura Health. - The series is led by board members Carissa Hocevar, a two-time Stage IV stomach cancer survivor whose treatment included a clinical trial, and Kelsea Lozada, a clinical trials educator focused on research awareness and access. - The series brings together patients, survivors, caregivers, clinicians, advocates and nonprofit leaders to discuss cancer care, clinical trials, survivorship and the patient experience. - Insights from the series may help inform future research, education, clinical trial awareness and patient-centered innovation. - GLOW collaborates with Cleveland Clinic, MD Anderson Cancer Center, Baptist Health Miami Cancer Institute, Northwell Health and Mount Sinai Medical Center. - GLOW's nonprofit and advocacy collaborators include CancerCare, Imerman Angels, Smart Patients, Triage Cancer and Blood Cancers United. - GLOW also acknowledges support from Merck, BeOne, Daiichi Sankyo, Salura Health and other nonprofit and community partners. - GLOW Oncology is a nonprofit focused on patient advocacy, education, health equity and innovation in cancer care. - More information is available on GLOW Oncology's website.

Between the lines: - GLOW is building a model that combines event fundraising, patient education and digital outreach rather than relying on a single program. - The mix of hospital partners, advocacy groups and corporate supporters suggests the nonprofit is trying to become a connector across the cancer care ecosystem. - The TikTok education series points to a younger, more digital patient outreach strategy that could broaden engagement beyond traditional oncology settings.

What's next: - The Sept. 17 launch will serve as the nonprofit's public introduction and fundraising push. - The Nov. 6 symposium in Miami Beach is the next major milestone and the clearest test of GLOW's ability to turn visibility into programming. - GLOW is likely to continue seeking sponsors and partners as it expands patient education and clinical trial awareness efforts.

The bottom line: - GLOW Oncology is using its launch to turn attention into support for a broader patient-education platform centered on GI/GU cancer care.